Efthymios Deliargyris
Efthymios Deliargyris publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research and Coronary Interventions and Diagnostics.
- World rank
- #828,455 of 7,710,434 ranked researchers
- Rank in United States
- #275,567 of 1,627,098
- Works
- 205
- Citations
- 3.9k
- Citations per work
- 18.9
What does Efthymios Deliargyris research?
Efthymios Deliargyris's work is mostly in Medicine (74%), Engineering (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15274.2%
- Medicine15274.2%
- Everything else4421.6%
- Physical Sciences94.2%
- Engineering94.2%
- 1Cardiology and Cardiovascular Medicine42% of their works
- 2Surgery22% of their works
- 3Pulmonary and Respiratory Medicine4% of their works
- 4Biomedical Engineering4% of their works
- 5Internal Medicine4% of their works
- 6Epidemiology3% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Heparin-Induced Thrombocytopenia and Thrombosis
- Atrial Fibrillation Management and Outcomes
- Mechanical Circulatory Support Devices
- Venous Thromboembolism Diagnosis and Management
- Cardiac and Coronary Surgery Techniques
Which keywords describe Efthymios Deliargyris's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Guidelines, Aspirin, Clopidogrel, Acute Coronary Syndromes, Myocardial Infarction, Thrombosis and Diagnosis.
- Coronary Artery Bypass Surgery
- Venous Thromboembolism
- Left Ventricular Assist Device
- Atrial Fibrillation
- Vaccination
- Myocardial Revascularization
- Diagnosis
- Myocardial Infarction
- Clopidogrel
- Guidelines
- Percutaneous Coronary Intervention
- Aspirin
- Acute Coronary Syndromes
- Thrombosis
- Coronary Stents
- Heparin-Induced Thrombocytopenia
- Anticoagulant Therapy
- Extracorporeal Membrane Oxygenation
- Antithrombotic Therapy
- Cardiopulmonary Bypass
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Percutaneous Coronary Intervention1583 topics
- Guidelines1082 topics
- Aspirin931 topic
- Clopidogrel931 topic
- Acute Coronary Syndromes721 topic
- Myocardial Infarction721 topic
- Thrombosis632 topics
- Diagnosis622 topics
- Coronary Stents401 topic
- Myocardial Revascularization401 topic
- Heparin-Induced Thrombocytopenia381 topic
- Vaccination381 topic
- Anticoagulant Therapy361 topic
- Atrial Fibrillation361 topic
- Extracorporeal Membrane Oxygenation251 topic
- Left Ventricular Assist Device251 topic
- Antithrombotic Therapy241 topic
- Venous Thromboembolism241 topic
- Cardiopulmonary Bypass181 topic
- Coronary Artery Bypass Surgery181 topic
Where does Efthymios Deliargyris work?
Efthymios Deliargyris's main affiliation in the publication record is Doctors Company (United States), United States.
How many publications and citations does Efthymios Deliargyris have?
OpenAlex counts 205 works and 3,879 citations for Efthymios Deliargyris, an h-index of 34, ranking #828,455 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Efthymios Deliargyris. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.